BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3092398)

  • 21. Electroblot and immunoperoxidase staining for rapid screening of the abnormalities of the multimeric structure of von Willebrand factor in von Willebrand's disease.
    Lombardi R; Gelfi C; Righetti PG; Lattuada A; Mannucci PM
    Thromb Haemost; 1986 Apr; 55(2):246-9. PubMed ID: 3520937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of human thrombin to human factor VIII:RAg.
    Hau L; Firkin BG; Howard MA
    Br J Haematol; 1986 Mar; 62(3):479-85. PubMed ID: 3082349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein.
    Fukui H; Yoshioka A; Mikami S; Takase T; Fujimura Y; Takahashi Y; Nishino M; Iwagaki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):839-50. PubMed ID: 121660
    [No Abstract]   [Full Text] [Related]  

  • 24. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome.
    Rose PE; Enayat SM; Sunderland R; Short PE; Williams CE; Hill FG
    Arch Dis Child; 1984 Dec; 59(12):1135-40. PubMed ID: 6441524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families.
    Mahasandana C; Suvatte V; Püng-amritt P; Tuchinda S
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):243-7. PubMed ID: 316576
    [No Abstract]   [Full Text] [Related]  

  • 28. von Willebrand disease: a common pediatric disorder.
    Montgomery RR; Kroner PA
    Pediatr Ann; 2001 Sep; 30(9):534-40. PubMed ID: 11554262
    [No Abstract]   [Full Text] [Related]  

  • 29. Properties of post-infusion factor VIII in von Willebrand's disease.
    Muntz RH; Ekert H; Helliger H
    Thromb Res; 1974 Aug; 5(2):111-23. PubMed ID: 4547286
    [No Abstract]   [Full Text] [Related]  

  • 30. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
    Warrier AI; Lusher JM
    J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand's disease (author's transl)].
    Mazurier C; Parquet-Gernez A; Goudemand M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():18-24. PubMed ID: 353655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor VIII/von Willebrand factor.
    Zimmerman TS; Ruggeri ZM; Fulcher CA
    Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
    [No Abstract]   [Full Text] [Related]  

  • 35. [Determination of factor VIII antigen (VIIIR-Ag) by erythrocyte agglutination].
    Coelho E
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):273-6. PubMed ID: 3138751
    [No Abstract]   [Full Text] [Related]  

  • 36. An improvemed assay for von Willebrand factor.
    Head DR; Bowman RP; Marmer DJ; Brossoit AD
    Am J Clin Pathol; 1979 Dec; 72(6):991-5. PubMed ID: 117698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex.
    Aihara M; Sawada Y; Ueno K; Morimoto S; Yoshida Y; de Serres M; Cooper HA; Wagner RH
    Thromb Haemost; 1986 Apr; 55(2):263-7. PubMed ID: 3087003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-molecular-weight factor VIII.
    Bouma BN; Sixma JJ; van Mourik JA; Mochtar IA
    Lancet; 1973 May; 1(7810):1001. PubMed ID: 4121556
    [No Abstract]   [Full Text] [Related]  

  • 39. The association of FVIII:C with the various molecular forms of FVIIIRAg present in clinical concentrates.
    Seghatchian MJ; Mackie IJ
    Thromb Res; 1983 Feb; 29(4):447-52. PubMed ID: 6407137
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet von Willebrand factor: comparison with plasma von Willebrand factor.
    Gralnick HR; Williams SB; McKeown LP; Krizek DM; Shafer BC; Rick ME
    Thromb Res; 1985 Jun; 38(6):623-33. PubMed ID: 3927508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.